Chronic Kidney Disease (CKD)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: CKD patients received renal biopsy (Informed concent should be obtained before renal biopsy. If impossible, IC obtained until one month after renal biopsy can be available)
Exclusion criteria
Exclusion criteria: 1. Unilateral kidney, severe unilateral kidney atrophy, functionally unilateral kidney 2.patients with malignancy (if they are free over one year without no medication to the malignant disease, they are possible to attend this study)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary end-point (composite end-point): total mortality, renal death, cerebro-cardiovascular event (ischemic heart disease, cerebral hemorrhage, cerebral infarction), 50% reduction in eGFR | — |
Secondary
| Measure | Time frame |
|---|---|
| decline rate of eGFR | — |
Countries
Japan
Contacts
National Hospital Organization Chiba-East Hospital Division of Nephrology, Diabetes, and Endocrinology